$235 Million is the total value of PURA VIDA INVESTMENTS, LLC's 74 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 61.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
AGN | Sell | ALLERGAN PLCput | $9,821,000 | -56.9% | 42,500 | -50.0% | 4.18% | -59.7% |
AET | Buy | AETNA INC NEW | $9,465,000 | +110.6% | 77,500 | +93.8% | 4.02% | +96.9% |
CNC | Buy | CENTENE CORP DEL | $7,494,000 | +298.8% | 105,000 | +244.0% | 3.19% | +273.1% |
FXH | Buy | FIRST TR EXHANGE TRADED FDput | $7,368,000 | +39.1% | 125,000 | +31.6% | 3.13% | +30.1% |
MDT | New | MEDTRONIC PLC | $6,942,000 | – | 80,000 | +100.0% | 2.95% | – |
BAX | Sell | BAXTER INTL INC | $6,661,000 | +4.6% | 147,305 | -5.0% | 2.83% | -2.2% |
ZBH | Buy | ZIMMER BIOMET HLDGS INC | $6,621,000 | +73.5% | 55,000 | +53.6% | 2.81% | +62.1% |
XLV | Buy | SELECT SECTOR SPDR TRput | $6,453,000 | +217.4% | 90,000 | +200.0% | 2.74% | +196.9% |
BDX | New | BECTON DICKINSON & COput | $6,360,000 | – | 37,500 | +100.0% | 2.70% | – |
BMY | Buy | BRISTOL MYERS SQUIBB CO | $6,344,000 | +31.5% | 86,250 | +14.2% | 2.70% | +23.0% |
SHPG | Buy | SHIRE PLCsponsored adr | $5,522,000 | +38.2% | 30,000 | +29.0% | 2.35% | +29.2% |
UHS | Sell | UNIVERSAL HLTH SVCS INCcl b | $5,364,000 | -14.0% | 40,000 | -20.0% | 2.28% | -19.6% |
EVHC | Buy | ENVISION HEALTHCARE HLDGS IN | $5,328,000 | +49.2% | 210,000 | +20.0% | 2.26% | +39.6% |
ALXN | Buy | ALEXION PHARMACEUTICALS INC | $5,216,000 | +4.1% | 44,670 | +24.1% | 2.22% | -2.7% |
MCK | Buy | MCKESSON CORP | $5,133,000 | +76.5% | 27,500 | +48.6% | 2.18% | +64.9% |
SYK | New | STRYKER CORP | $4,793,000 | – | 40,000 | +100.0% | 2.04% | – |
LLY | Buy | LILLY ELI & CO | $4,410,000 | +45.8% | 56,000 | +33.3% | 1.88% | +36.4% |
PODD | Sell | INSULET CORP | $4,400,000 | -24.2% | 145,500 | -16.9% | 1.87% | -29.1% |
ALXN | New | ALEXION PHARMACEUTICALS INCput | $4,379,000 | – | 37,500 | +100.0% | 1.86% | – |
NXTM | Sell | NXSTAGE MEDICAL INC | $4,336,000 | +20.4% | 200,000 | -16.7% | 1.84% | +12.6% |
BSX | Sell | BOSTON SCIENTIFIC CORP | $4,323,000 | -23.4% | 185,000 | -38.3% | 1.84% | -28.4% |
GSK | New | GLAXOSMITHKLINE PLCsponsored adr | $4,296,000 | – | 99,125 | +100.0% | 1.83% | – |
OMI | Buy | OWENS & MINOR INC NEW | $4,164,000 | -1.9% | 111,400 | +6.1% | 1.77% | -8.3% |
AMGN | Buy | AMGEN INC | $4,146,000 | +8.1% | 27,250 | +6.5% | 1.76% | +1.1% |
PFE | Sell | PFIZER INC | $4,143,000 | -30.1% | 117,675 | -41.2% | 1.76% | -34.7% |
ATHN | ATHENAHEALTH INC | $4,140,000 | -0.6% | 30,000 | 0.0% | 1.76% | -7.0% | |
CELG | Buy | CELGENE CORP | $4,130,000 | +115.8% | 41,875 | +119.0% | 1.76% | +101.8% |
ABT | Sell | ABBOTT LABS | $3,931,000 | -24.8% | 100,000 | -20.0% | 1.67% | -29.7% |
WMGI | Buy | WRIGHT MED GROUP N V | $3,908,000 | +11.1% | 225,000 | +6.2% | 1.66% | +3.8% |
CVS | New | CVS HEALTH CORP | $3,830,000 | – | 40,000 | +100.0% | 1.63% | – |
TMO | Sell | THERMO FISHER SCIENTIFIC INCput | $3,694,000 | -13.0% | 25,000 | -16.7% | 1.57% | -18.7% |
IVC | Buy | INVACARE CORP | $3,548,000 | +19.7% | 292,500 | +30.0% | 1.51% | +12.0% |
CYNA | Buy | CYNAPSUS THERAPEUTICS INC | $3,364,000 | +42.6% | 200,845 | +3.3% | 1.43% | +33.3% |
SPNC | Sell | SPECTRANETICS CORP | $3,274,000 | -16.8% | 175,000 | -35.4% | 1.39% | -22.2% |
JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $3,109,000 | +217.6% | 22,000 | +193.3% | 1.32% | +197.1% |
CPHD | New | CEPHEID | $2,921,000 | – | 95,000 | +100.0% | 1.24% | – |
CYNO | New | CYNOSURE INCcl a | $2,919,000 | – | 60,000 | +100.0% | 1.24% | – |
XENT | New | INTERSECT ENT INC | $2,780,000 | – | 215,000 | +100.0% | 1.18% | – |
OPHT | Buy | OPHTHOTECH CORP | $2,679,000 | +95.0% | 52,500 | +61.5% | 1.14% | +82.2% |
CSII | New | CARDIOVASCULAR SYS INC DEL | $2,670,000 | – | 145,289 | +100.0% | 1.14% | – |
ELGX | Sell | ENDOLOGIX INC | $2,554,000 | -30.0% | 205,000 | -53.0% | 1.09% | -34.5% |
AMRN | AMARIN CORP PLCspons adr new | $2,349,000 | +41.2% | 1,087,500 | 0.0% | 1.00% | +32.0% | |
SIEN | Buy | SIENTRA INC | $2,303,000 | +16.3% | 350,000 | +20.9% | 0.98% | +8.8% |
HRC | New | HILL ROM HLDGS INC | $2,270,000 | – | 45,000 | +100.0% | 0.96% | – |
MDVN | Sell | MEDIVATION INC | $2,186,000 | +27.6% | 36,250 | -2.7% | 0.93% | +19.3% |
VAR | New | VARIAN MED SYS INCput | $2,056,000 | – | 25,000 | +100.0% | 0.87% | – |
AKRXQ | Buy | AKORN INC | $2,022,000 | +201.3% | 71,000 | +149.1% | 0.86% | +182.0% |
AVXS | New | AVEXIS INC | $1,931,000 | – | 50,800 | +100.0% | 0.82% | – |
KITE | KITE PHARMA INC | $1,863,000 | +8.9% | 37,250 | 0.0% | 0.79% | +1.8% | |
AGN | Sell | ALLERGAN PLC | $1,830,000 | -83.9% | 7,920 | -81.4% | 0.78% | -85.0% |
GWPH | New | GW PHARMACEUTICALS PLCcall | $1,648,000 | – | 18,000 | +100.0% | 0.70% | – |
ATRC | Sell | ATRICURE INC | $1,556,000 | -25.1% | 110,098 | -10.8% | 0.66% | -30.1% |
IVC | INVACARE CORPcall | $1,517,000 | -7.9% | 125,000 | 0.0% | 0.64% | -13.9% | |
VIVE | New | VIVEVE MED INC | $1,513,000 | – | 368,919 | +100.0% | 0.64% | – |
NUVA | New | NUVASIVE INC | $1,493,000 | – | 25,000 | +100.0% | 0.64% | – |
FLKS | FLEX PHARMA INC | $1,450,000 | -6.9% | 142,000 | 0.0% | 0.62% | -13.0% | |
SGYPQ | Sell | SYNERGY PHARMACEUTICALS DEL | $1,330,000 | -15.9% | 350,000 | -38.9% | 0.56% | -21.4% |
XENT | New | INTERSECT ENT INCcall | $1,293,000 | – | 100,000 | +100.0% | 0.55% | – |
OPHT | New | OPHTHOTECH CORPcall | $1,276,000 | – | 25,000 | +100.0% | 0.54% | – |
WMGIZ | WRIGHT MED GROUP N Vright 03/01/2019 | $740,000 | +0.8% | 586,936 | 0.0% | 0.32% | -5.7% | |
ALQA | Buy | ALLIQUA BIOMEDICAL INC | $653,000 | +55.8% | 583,026 | +14.0% | 0.28% | +45.5% |
FOMX | FOAMIX PHAMACEUTICALS LTD | $648,000 | -2.6% | 102,000 | 0.0% | 0.28% | -8.9% | |
TNXP | Buy | TONIX PHARMACEUTICALS HLDG C | $567,000 | +47.3% | 284,877 | +78.2% | 0.24% | +37.7% |
ITEK | INOTEK PHARMACEUTICALS CORP | $558,000 | +0.5% | 75,000 | 0.0% | 0.24% | -6.0% | |
FPRX | FIVE PRIME THERAPEUTICS INC | $548,000 | +1.9% | 13,250 | 0.0% | 0.23% | -4.9% | |
ZGNX | ZOGENIX INC | $473,000 | -12.9% | 58,750 | 0.0% | 0.20% | -18.6% | |
ALDX | Buy | ALDEYRA THERAPEUTICS INC | $441,000 | +83.0% | 77,500 | +34.8% | 0.19% | +70.0% |
ADMP | Buy | ADAMIS PHARMACEUTICALS CORP | $435,000 | -11.8% | 155,500 | +93.2% | 0.18% | -17.4% |
New | NEURODERM LTD | $401,000 | – | 24,683 | +100.0% | 0.17% | – | |
IMMU | Buy | IMMUNOMEDICS INC | $271,000 | +49.7% | 116,743 | +61.0% | 0.12% | +40.2% |
OCRX | OCERA THERAPEUTICS INC | $249,000 | -35.3% | 131,000 | 0.0% | 0.11% | -39.4% | |
ADMA | New | ADMA BIOLOGICS INC | $217,000 | – | 36,500 | +100.0% | 0.09% | – |
New | NEOVASC INC | $135,000 | – | 262,060 | +100.0% | 0.06% | – | |
STDY | New | STEADYMED LTD | $94,000 | – | 28,758 | +100.0% | 0.04% | – |
OCUL | Exit | OCULAR THERAPEUTIX INC | $0 | – | -6,000 | -100.0% | -0.03% | – |
CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -56,000 | -100.0% | -0.04% | – |
HTBX | Exit | HEAT BIOLOGICS INC | $0 | – | -240,815 | -100.0% | -0.08% | – |
VNDA | Exit | VANDA PHARMACEUTICALS INC | $0 | – | -67,500 | -100.0% | -0.26% | – |
CPXX | Exit | CELATOR PHARMACEUTICALS INC | $0 | – | -55,000 | -100.0% | -0.28% | – |
NXTM | Exit | NXSTAGE MEDICAL INCcall | $0 | – | -50,000 | -100.0% | -0.34% | – |
FOLD | Exit | AMICUS THERAPEUTICS INCcall | $0 | – | -100,000 | -100.0% | -0.38% | – |
FLDM | Exit | FLUIDIGM CORP DEL | $0 | – | -125,000 | -100.0% | -0.46% | – |
SGNT | Exit | SAGENT PHARMACEUTICALS INC | $0 | – | -89,713 | -100.0% | -0.50% | – |
ANGO | Exit | ANGIODYNAMICS INCcall | $0 | – | -100,000 | -100.0% | -0.56% | – |
EWA | Exit | ISHAREScall | $0 | – | -75,000 | -100.0% | -0.66% | – |
HTWR | Exit | HEARTWARE INTL INC | $0 | – | -50,000 | -100.0% | -0.71% | – |
SRPT | Exit | SAREPTA THERAPEUTICS INCput | $0 | – | -100,000 | -100.0% | -0.89% | – |
BIIB | Exit | BIOGEN INC | $0 | – | -7,500 | -100.0% | -0.89% | – |
MYL | Exit | MYLAN N V | $0 | – | -44,000 | -100.0% | -0.93% | – |
SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -10,000 | -100.0% | -0.93% | – |
ALGN | Exit | ALIGN TECHNOLGY INCput | $0 | – | -30,000 | -100.0% | -0.99% | – |
TFX | Exit | TELEFLEX INCput | $0 | – | -15,000 | -100.0% | -1.07% | – |
TFX | Exit | TELEFLEX INC | $0 | – | -15,000 | -100.0% | -1.07% | – |
ARAY | Exit | ACCURAY INC | $0 | – | -441,300 | -100.0% | -1.16% | – |
ACAD | Exit | ACADIA PHARMACEUTICALS INCcall | $0 | – | -100,000 | -100.0% | -1.27% | – |
A | Exit | AGILENT TECHNOLOGIES INC | $0 | – | -90,000 | -100.0% | -1.63% | – |
SPY | Exit | SPDR S&P 500 ETF TRcall | $0 | – | -20,000 | -100.0% | -1.87% | – |
NUVA | Exit | NUVASIVE INCcall | $0 | – | -120,000 | -100.0% | -2.65% | – |
ABBV | Exit | ABBVIE INC | $0 | – | -104,875 | -100.0% | -2.72% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ICU MED INC | 26 | Q2 2023 | 4.2% |
NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
VIEWRAY INC | 25 | Q2 2023 | 3.2% |
LIVANOVA PLC | 23 | Q3 2023 | 3.8% |
ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
INSPIRE MED SYS INC | 22 | Q3 2023 | 3.7% |
BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
INVACARE CORP | 22 | Q3 2021 | 2.8% |
ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 5.0% |
INTERSECT ENT INC | 21 | Q2 2021 | 2.6% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
ESTABLISHMENT LABS HOLDINGS INC. | February 14, 2023 | 1,002,767 | 4.1% |
Pulmonx Corp | February 14, 2023 | 1,216,258 | 3.2% |
Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
Universe Pharmaceuticals INCSold out | February 14, 2023 | 0 | 0.0% |
MedMen Enterprises, Inc. | April 29, 2022 | 139,755,072 | 21.4% |
INVACARE CORPSold out | February 14, 2022 | 0 | 0.0% |
MedAvail Holdings, Inc. | February 14, 2022 | 714,120 | 2.2% |
TELA Bio, Inc. | February 14, 2022 | 564,120 | 3.9% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2024-02-13 |
SC 13D/A | 2023-12-29 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.